• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIT 8.20% 5.6¢

BIOTRON LIMITED - Corporate Spotlight

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

(20min delay)
Last
5.6¢
Change
-0.005(8.20%)
Mkt cap ! $50.52M
Open High Low Value Volume
6.0¢ 6.1¢ 5.6¢ $193.1K 3.308M

Buyers (Bids)

No. Vol. Price($)
2 91473 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.8¢ 159890 1
View Market Depth
Last trade - 16.10pm 29/04/2024 (20 minute delay) ?
Last
5.6¢
  Change
-0.005 ( 8.20 %)
Open High Low Volume
6.2¢ 6.2¢ 5.6¢ 501366
Last updated 15.56pm 29/04/2024 ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.